ClinConnect ClinConnect Logo
Search / Trial NCT06711536

TRISS as a Predictor of Trauma Patient Outcomes

Launched by AL-NAHRAIN UNIVERSITY · Nov 28, 2024

Trial Information

Current as of September 08, 2025

Recruiting

Keywords

Triss

ClinConnect Summary

This clinical trial, called TRISS as a Predictor of Trauma Patient Outcomes, is studying how well the Trauma and Injury Severity Score (TRISS) can predict the chances of survival and other important outcomes for patients who have experienced trauma. The study is taking place at Kadhimiya Educational Hospital in Iraq and aims to see if TRISS can help doctors understand how likely it is that a trauma patient will need intensive care, surgery, or have a longer hospital stay.

To participate in this study, patients must be at least 18 years old and have been admitted to the emergency department due to trauma. Importantly, the study will assess patients using the TRISS score within the first hour of their arrival to get timely information. Throughout their hospital stay, the medical team will monitor their recovery, including whether they survive, need intensive care, or require surgery. This trial is currently looking for participants and aims to provide valuable insights that could help improve care for trauma patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Trauma patients admitted to the emergency department of Al-Kadhimiya Teaching Hospital.
  • Patients with adequate documentation of physiological and anatomical data are required for TRISS calculation.
  • Trauma scoring (TRISS) completed within the first 6 hours of hospital arrival to ensure timely assessment.
  • Exclusion Criteria:
  • Patients under 18 years, pregnant women, or those with conditions that alter standard trauma scoring or management.
  • Non-trauma cases (e.g., medical emergencies, terminal illnesses) to ensure focus on trauma-specific outcomes.
  • Patients with incomplete or missing data required for TRISS calculation.
  • Patients declared dead on arrival or those not treated in the trauma and emergency department.
  • Individuals refusing participation or withdrawing consent at any stage of the study.
  • Patients transferred to or from another facility or enrolled in other studies that might affect scoring accuracy or outcomes.

About Al Nahrain University

Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.

Locations

Baghdad, , Iraq

Patients applied

0 patients applied

Trial Officials

Mohammed A. Hamdawi, Professor

Study Director

College Of Medicine - Nahrain University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported